- Home
- SHIP vs ENTA Comparison
SHIP vs ENTA Comparison
Compare SHIP & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- ENTA
- Stock Information
- Founded
- SHIP 2008
- ENTA 1995
- Country
- SHIP Greece
- ENTA United States
- Employees
- SHIP N/A
- ENTA N/A
- Industry
- SHIP Marine Transportation
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- SHIP Consumer Discretionary
- ENTA Health Care
- Exchange
- SHIP Nasdaq
- ENTA Nasdaq
- Market Cap
- SHIP 170.0M
- ENTA 164.6M
- IPO Year
- SHIP 2007
- ENTA 2013
- Fundamental
- Price
- SHIP $8.31
- ENTA $10.75
- Analyst Decision
- SHIP Strong Buy
- ENTA Strong Buy
- Analyst Count
- SHIP 1
- ENTA 5
- Target Price
- SHIP $11.00
- ENTA $21.00
- AVG Volume (30 Days)
- SHIP 141.4K
- ENTA 1.6M
- Earning Date
- SHIP 11-07-2025
- ENTA 11-24-2025
- Dividend Yield
- SHIP 9.23%
- ENTA N/A
- EPS Growth
- SHIP N/A
- ENTA N/A
- EPS
- SHIP 0.73
- ENTA N/A
- Revenue
- SHIP $147,718,000.00
- ENTA $64,806,000.00
- Revenue This Year
- SHIP N/A
- ENTA $0.07
- Revenue Next Year
- SHIP $11.82
- ENTA N/A
- P/E Ratio
- SHIP $11.30
- ENTA N/A
- Revenue Growth
- SHIP 1.66
- ENTA N/A
- 52 Week Low
- SHIP $4.78
- ENTA $4.09
- 52 Week High
- SHIP $10.16
- ENTA $15.34
- Technical
- Relative Strength Index (RSI)
- SHIP 49.34
- ENTA 52.20
- Support Level
- SHIP $8.14
- ENTA $10.20
- Resistance Level
- SHIP $8.50
- ENTA $11.59
- Average True Range (ATR)
- SHIP 0.23
- ENTA 0.60
- MACD
- SHIP 0.01
- ENTA -0.18
- Stochastic Oscillator
- SHIP 61.90
- ENTA 25.77
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.